Tag: Adar Poonawalla

Poonawalla has reportedly briefed the Union Health Minister Mansukh Mandaviya on the issue in a meeting.

It was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination, said Adar Poonawalla on Friday

New Delhi: Debunking news reports that India has not placed fresh orders for Covid vaccines with the Serum Institute of India (SII) and Bharat BioTech since March, the Union government…

London: Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on…

Pune: Adar Poonawalla, Chief Executive Officer of Serum Institute of India (SII) which is producing the potential coronavirus vaccine developed by Oxford University, asked on Saturday if the government will have Rs 80,000 crore available to buy and distribute the vaccine. “Quick question; will the government of India have 80,000 crores available, over the next […]

New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. […]

Singapore: Adar Poonawalla, the chief executive of the world’s largest vaccine manufacturer Serum Institute of India, is among the six people named “Asians of the Year” by  The Straits Times, a leading daily newspaper of Singapore, for their work in fighting the COVID-19 pandemic. Pune-based Serum Institute of India (SII) has collaborated with the University […]

New Delhi: Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India’s first Covid-19 vaccine will roll out in the coming weeks. Poonawalla said SII risks on stockpiling the vaccine have paid off. His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield […]

New Delhi: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost Rs 219-292 per shot to the government and will be priced at double that rate in private market ones such sales open up, said Adar Poonawalla, the CEO of its Indian manufacturer-Serum Institute of India, on Monday. Serum Institute of India […]

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]

New Delhi: Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries, including the US and India is likely to derail efforts to deliver 2 billion doses to poorer and middle-income nations. In an interview with a global news wire, Poonawalla said countries are holding tight to their supplies and […]